News Muncher - searching for drug

1 week, 2 days ago

PLI boost: Cancer patients can hope for affordable drugs in India

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have started manufacturing key medicines for such diseases in the country. India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd., Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd and Biocon Ltd are making cancer drugs under one of the two Production …

Cancer Drugs Pharmaceuticals Manufacturing Rare Diseases Pharma Scheme

1 month, 1 week ago

Cipla expects to end FY25 exceeding margin guidance, beats Q3 earnings estimates

Live Mint

Pharma major Cipla Ltd on Tuesday posted its highest-ever quarterly revenue and Ebitda margin, as robust sales in India, Europe and emerging markets outweighed weakness in its US business. Cipla expects to end the ongoing fiscal year exceeding its margin guidance, managing director and global CEO Umang Vohra said, as the Mumbai-based drugmaker beat estimates for revenue and profit for …

India Company End Drug Quarter Margin Cipla

1 month, 2 weeks ago

India’s Cipla beats Q3 profit view as strong domestic demand offset weak US sales

Live Mint

By Rishika Sadam and Kashish Tandon HYDERABAD/BENGALURU -Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by strong domestic demand, and said the U.S. freezing aid for some drug programs would not hurt its results. The company's consolidated net profit increased nearly 49% to 15.71 billion rupees in the October-December quarter, beating analysts' …

India Drug Cipla Rupees Pepfar Q3 Profit

2 months, 2 weeks ago

Weight-loss drugs: A game changer for India’s top pharma companies

Live Mint

Over 650 million adults globally suffer from obesity, and this number is only expected to rise. India’s rising players in the GLP-1 market Indian pharmaceutical giants like Sun Pharma, Cipla, Dr. Reddy’s, Natco Pharma, and Lupin are in a fierce race to bring obesity drugs to the Indian market. Cipla: Entering the market with generics Cipla, one of India’s most …

India Weight Loss Loss Indian Obesity Companies Weight

4 months, 2 weeks ago

Cipla's Share Price Soars 10% After FDA Grants Voluntary Action Indicated Status in Goa Facility

India Today

Cipla's stock surged by 9.88% today after the US Food and Drug Administration (USFDA) granted its Goa facility a 'Voluntary Action Indicated (VAI)' status. This means that while certain observations were made during the June inspection, the regulator does not require immediate corrective action. This is a positive news for Cipla, as it signals that the regulatory issues identified are …

Business Science Law Markets Goa

7 months, 3 weeks ago

Cipla gets ₹773 crore demand notice from income tax department. Here’s why

Live Mint

Leading pharmaceutical manufacturer Cipla Ltd received an additional tax demand of ₹773.44 crore from the income tax department for assessment years 2015-16 to 2022-23, the drug maker said in a stock exchange filing on July 16. The tax authority has asked for additional taxes, citing rule violations, including short deductions, weighted deductions, and disallowances of various expenses under the Income …

Income Tax Company Cipla Crore Demand

1 year, 4 months ago

Cipla net soars 43% on growth in India, other key markets

Live Mint

Cipla Ltd posted a 43.4% rise in consolidated net profit for the quarter ended September to ₹1,130.91 crore, against ₹788.90 crore in the corresponding quarter of last year. The drug major’s Q2FY24 revenue increased 14.6% from a year ago from ₹5,828.54 crore to ₹6,678.15 crore, driven by performance in India, the US, and South Africa, it said in an exchange …

Business India South Africa Company Crore Quarter Key

1 year, 6 months ago

NMC: A prescription for change in medicine and markets?

The Hindu

The National Medical Commission’s recent directive, gazetted just two weeks ago, urging doctors to prescribe solely generic medicines, has met with widespread resistance from both doctors and the pharmaceutical industry. It’s noteworthy that unbranded generics typically cost between 30%-80% less than their original brand or branded generic counterparts. In an ecosystem devoid of branded generics, novel opportunities for distributors dealing …

India Medical Medicine Change Quality Indian Public Welfare

1 year, 7 months ago

Strong US sales growth, sustained domestic momentum helps Cipla beat estimates

Live Mint

Cipla's performance in the April-June quarter came better than expectations largely due to strong US sales performance. The analysts feel that contributions from multiple myeloma treatment drug Revlimid generics also contributed to the US sales growth. South Africa Private Market business grew at 13% YoY in local currency terms backed by double digit growth in both prescription and OTC business, …

Business India Market South Africa Launch Crore Yoy

1 year, 7 months ago

Cipla Q1 net profit rises 45% to ₹996 crore; revenue growth at 18% YoY

Live Mint

Cipla reported a 45.1% rise in its consolidated net profit for the quarter ended June 2023 at ₹995.7 crore as compared to ₹696.4 crore in the corresponding quarter of the last year. The company’s US business reported the highest ever revenue of $ 222 million, registering a growth of 43% YoY growth driven by robust momentum in differentiated portfolios. South …

Business Growth Crore Yoy Cipla Profit Rises

2 years, 2 months ago

India-Australia FTA: Cipla, Lupin, Sun And Other Top Drugmakers to Go Down Under in Bid to Push Up Exports

News 18

India is looking at greater market access for its pharmaceutical products in Australia as its top drugmakers are set to visit the country in the first week of February, News18.com has learnt. The tour is a part of the pharmaceutical supply chain resilience initiative following India’s free trade agreement with Australia. All the top drugmakers of India such as Sun …

India Australia Pharmaceutical Drug Fta

2 years, 4 months ago

India@75: Phenomenal journey of the pharma industry

Hindustan Times

The Indian pharmaceutical industry has come a long way since the country’s independence. Among private players, Khwaja Abdul Hamied had already set up one of India’s oldest pharma companies, Cipla in 1935; Indravan Modi set up Cadila pharmaceuticals in the early 1950s, Kallam Anji Reddy set up Dr Reddy’s Laboratories in Hyderabad and Bhai Parvinder Singh set up Ranbaxy in …

Research Medical World Drugs Pharma Covid Drug

3 years, 2 months ago

Mankind Pharma to Launch Cheapest Covid Antiviral Drug Molnupiravir at Rs 35 Per Capsule by Next Week

News 18

Mankind Pharma’s chairman has said the company’s will launch the cheapest Molnupiravir, the Covid-19 antiviral drug, at Rs 35 per capsule, the Economic Times said in a report. Molnupiravir, developed by MSD and Ridgeback Biotherapeutics, has been approved by the UK Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration for the treatment of mild-to-moderate Covid-19 …

Pharma Covid Mankind Pharma Cipla Capsule Launch Molnupiravir

3 years, 6 months ago

Cipla Wants Modi Govt to Hike Prices of Asthma Drugs, Cites 300% Increase in Production Cost

News 18

New Delhi: Drug major Cipla has asked the Narendra Modi government at the Centre to allow price hike of asthma and other respiratory drugs, citing a 300 per cent increase in production cost, News18 has learnt. In a letter written by the Mumbai-based pharma firm to the country’s drug price regulator, National Pharmaceuticals Pricing Authority, the company has highlighted the …

Cipla Price Hike Hike Prices Production Cost Propellant

3 years, 8 months ago

Moderna vaccines expected to reach India in next 2-3 days

India Today

After getting approval from the Drug Controller General of India, the Government of India is expecting US manufactured Moderna vaccine doses to reach India in the next few days. US vaccine manufacturing giant Moderna had earlier this week secured restricted emergency use authorisation for its Covid-19 vaccine in India. According to the World Health Organisation, the Moderna vaccine has shown …

India Cipla Dcgi Moderna Vaccine

3 years, 8 months ago

Moderna's COVID-19 vaccine gets approval for restricted emergency use, confirms Centre

Firstpost

Earlier news agency PTI had reported that the DCGI has granted permission to Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country. Earlier, quoting official sources, news agency PTI had reported that India’s drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country. …

India Emergency Vaccines Covid Paul Pti Approval

3 years, 8 months ago

Cipla gets authorisation for restricted use in India of donated Moderna vaccines

Live Mint

NEW DELHI: Pharmaceutical giant Cipla Ltd has received an import licence for restricted emergency use of Moderna’s covid-19 messenger RNA vaccine in India which have been donated by the US-based firm. “An application received from Moderna through an Indian partner, Cipla, has been granted new drug permission for restricted use, which is commonly known as emergency use authorisation. This new …

India Vaccine Moderna Cipla Rna

3 years, 8 months ago

Cipla gets Indian government nod to import Moderna’s COVID-19 vaccine

The Hindu

The Drugs Controller General of India, on Tuesday, granted permission to Mumbai-based pharmaceutical firm Cipla to import Moderna’s COVID-19 vaccine, making it the fourth vaccine in the country to be given the Emergency Use Authorisation. Announcing this at the Health Ministry press conference on Tuesday, NITI Aayog’s member V. K. Paul said the finer modalities are being worked out for …

Vaccine Moderna Gets India Paul Cipla

3 years, 8 months ago

Moderna's Covid-19 vaccine gets emergency use nod from DCGI

India Today

US vaccine manufacturing giant Moderna has secured restricted emergency use authorisation for its Covid-19 vaccine in India. Besides this, Indian drug manufacturer Cipla has been given permission to import Moderna's Covid-19 vaccine. "An application was received from Moderna through their Indian partner Cipla following which Moderna's Covid-19 vaccine has been granted restricted emergency use authorisation by the drug regulator. Besides …

India Indian Vaccines Cipla Developed Dcgi Import

3 years, 8 months ago

Moderna seeks DCGI approval for Covid-19 vaccine in India, Cipla for import licence, sale

India Today

Moderna has sought regulatory approval for its Covid-19 vaccine in India. According to official sources, India's drug regulator may soon grant restricted emergency use authorisation for Moderna's Covid-19 vaccine. The Drug Controller General of India is likely to approve Moderna's Covid-19 vaccine for emergency use in those aged 18 and above, sources told India Today on Tuesday. Mumbai-based pharmaceutical company …

India Covid Vaccine Moderna Cipla Dcgi

3 years, 9 months ago

Probe How Celebrities, Politicians Got COVID Drugs : Bombay High Court Tells State

Live Law

The Bombay High Court on Thursday urged the State not to drop the ball on its inquiry into the private distribution of Remdesivir injections by politicians and celebrities after noting discrepancies in the responses received by the Drug Inspector. The bench said that while manufacturers seem to have told the Union of India that they have provided Remdesivir only to …

Drugs Hospitals State Drug Response Sood Manufacturers

3 years, 9 months ago

'New Weapon, Works on Variants': Top Doc Vouches for Cocktail Drug as First Recipient Discharged

News 18

The Antibody Cocktail, launched in India on Monday for treatment of mild to moderate COVID-19 in patients, is working against the disease, Dr Naresh Trehan said on Wednesday. One of the top doctors in the country, Trehan also said that the Antibody Cocktail, which is a combination of Casirivimab and Imdevimab, is effective against the B.1.617 variant of coronavirus, first …

India Drug High Risk Cocktail Cipla Cocktail Drug Roche India

3 years, 9 months ago

Roche launches COVID-19 'Antibody Cocktail' in India at Rs 59,750 per dose; Cipla to market drug in country

Firstpost

In a joint statement, the pharma giants said that the second batch of the Antibody Cocktail will be available by mid-June New Delhi: Drug majors Roche India and Cipla on Monday announced launch of Roche’s Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate COVID-19 in patients who are at high risk. …

India Treatment Patients High Risk Cocktail Cipla Roche

3 years, 9 months ago

Covid: Roche's antibody cocktail launched in India at Rs 59,750 per patient, Cipla to market it

India Today

Drug majors Roche India and Cipla on Monday announced launch of Roche's Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate Covid-19 in patients who are at high risk. In total they can potentially benefit 2,00,000 patients as each of the 1,00,000 packs that will be available in India offers treatment for …

India Treatment Patients Covid Patient High Risk Cocktail

Filters

Articles for Cipla, search results for drug

PLI boost: Cancer patients can hope for affordable drugs in India

Cipla expects to end FY25 exceeding margin guidance, beats Q3 earnings estimates

India’s Cipla beats Q3 profit view as strong domestic demand offset weak US sales

Weight-loss drugs: A game changer for India’s top pharma companies

Cipla's Share Price Soars 10% After FDA Grants Voluntary Action Indicated Status in Goa Facility

Cipla gets ₹773 crore demand notice from income tax department. Here’s why

Cipla net soars 43% on growth in India, other key markets

NMC: A prescription for change in medicine and markets?

Strong US sales growth, sustained domestic momentum helps Cipla beat estimates

Cipla Q1 net profit rises 45% to ₹996 crore; revenue growth at 18% YoY

India-Australia FTA: Cipla, Lupin, Sun And Other Top Drugmakers to Go Down Under in Bid to Push Up Exports

India@75: Phenomenal journey of the pharma industry

Mankind Pharma to Launch Cheapest Covid Antiviral Drug Molnupiravir at Rs 35 Per Capsule by Next Week

Cipla Wants Modi Govt to Hike Prices of Asthma Drugs, Cites 300% Increase in Production Cost

Moderna vaccines expected to reach India in next 2-3 days

Moderna's COVID-19 vaccine gets approval for restricted emergency use, confirms Centre

Cipla gets authorisation for restricted use in India of donated Moderna vaccines

Cipla gets Indian government nod to import Moderna’s COVID-19 vaccine

Moderna's Covid-19 vaccine gets emergency use nod from DCGI

Moderna seeks DCGI approval for Covid-19 vaccine in India, Cipla for import licence, sale

Probe How Celebrities, Politicians Got COVID Drugs : Bombay High Court Tells State

'New Weapon, Works on Variants': Top Doc Vouches for Cocktail Drug as First Recipient Discharged

Roche launches COVID-19 'Antibody Cocktail' in India at Rs 59,750 per dose; Cipla to market drug in country

Covid: Roche's antibody cocktail launched in India at Rs 59,750 per patient, Cipla to market it